Post Archive by Month

A new analysis of emergency department (ED) visits for pediatric urinary tract infections (UTIs sheds light on antibiotic prescribing practices, as reported today in the journal Pediatrics.
Published on June 11, 2024, the Research Brief assessed changes in antibiotic prescribing at ED visits for pediatric UTIs from 2011 to 2020 using nationally representative data from the National Hospital Ambulatory Medical Care Survey. A total of 1,083 UTI visits by non-pregnant patients ages 18 and younger were included in the analysis.

A Special Communication recently published by the JAMA Network stated that optimal healthcare delivery, both now and in the future, requires a continuous loop of knowledge generation, dissemination, and uptake on how best to provide care.
This perspective integrates determining what interventions work and how best to ensure they are provided to those who need them.
Most providers know that a randomized clinical trial (RCT) is the most rigorous instrument for determining what works in health care.

By Dennis Thompson HealthDay ReporterTUESDAY, June 11, 2024 (HealthDay News) — A new proposed definition for Long COVID could help patients get the help they need, a new report from …

Stanford Medicine researchers recently reported that an often-prescribed medication for treating COVID-19 did not produce measurable benefits for those suffering from Long COVID.
This disappointing news affects millions of people who are taking Pfizer Inc. Paxlovid™ to combat Long COVID.
A survey by the Agency for Healthcare Research and Quality recently concluded almost 18 million adults have ever had Long COVID.

While there are no U.S. FDA preventive vaccines and few chemoprophylaxis options targeting bacterial sexually transmitted infections (STIs), syphilis, chlamydia, and gonorrhea cases have increased in the United States.
In 2022, more than 2.5 million cases of syphilis, gonorrhea, and chlamydia were reported by the U.S. Centers for Disease Control and Prevention (CDC).
The most alarming concerns center around syphilis and congenital syphilis epidemics, signaling an urgent need for swift innovation and collaboration from all STI prevention partners, says the CDC.

The current varicella (chickenpox) outbreak in New York City emphasizes the significance of high vaccination coverage and the necessity for improved infrastructure to facilitate vaccinations for individuals who have recently arrived in the United States from countries that do not routinely administer this vaccination.

Since the COVID-19 pandemic began in late 2019, many people who contracted the SARS-CoV-2 coronavirus have been experiencing symptoms for extended periods, sometimes lasting for months or even years.
According to the Centers for Disease Control and Prevention, about 17% of Americans have experienced Long COVID.
Today, the National Academies of Sciences, Engineering, and Medicine released a new report to clarify which symptoms are associated with a Long COVID diagnosis.

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) has funded a new study led by researchers at the Albert Einstein College of Medicine in New York with $603,661.
Launched on June 1, 2024, the goal of this follow-up project (PA-20-185) is to accelerate the development of strategies to bolster vaccine and monoclonal antibody (mAb) efficacy against a range of pathogens such as herpes simplex virus (HSV).
The total project funding amount for the two projects is now $1,231,761.